A Mechanistic Insight into Beneficial Effects of Polyphenols in the Prevention and Treatment of Nephrolithiasis: Evidence from Recent In Vitro Studies
Source abstract
Abstract
Nephrolithiasis is a pathological condition characterized by the formation of solid crystals in the kidneys or other parts of urinary tract. Kidney stones are a serious public health issue and financial burden for health care system, as well as a painful and uncomfortable condition for patients, resulting in renal tissue injury in severe cases. Dietary habits, low fluid and high salt intake predominantly, contribute to the development of kidney stones. Current research suggests that polyphenols have a protective effect in the pathogenesis of kidney stones. Polyphenols are a group of naturally occurring compounds found in plant-based foods such as fruits, vegetables, tea, and coffee. In this review, we explore mechanisms underlying the beneficial effects of polyphenols, such as oxidative stress reduction and modulation of inflammatory pathways, in various in vitro models of nephrolithiasis. Additionally, certain polyphenols, such as catechins found in green tea, have been shown to inhibit the formation and growth of kidney stones in animal studies. This review highlights the antioxidant and anti-inflammatory effects, as well as the inhibition of crystal formation, as results of polyphenol treatment in vitro. Further research is required to determine the specific effects of polyphenols on kidney stone formation in humans; however, current knowledge implicates that incorporating a variety of polyphenol-rich foods into the diet may be a beneficial strategy for individuals at risk of developing nephrolithiasis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Kidney Stones and Urolithiasis Treatments · Heavy Metals in Plants · Mercury impact and mitigation studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia
Institute of Public Health Osijek-Baranja County, 31000 Osijek, Croatia
Clinical Institute of Nuclear Medicine and Radiation Protection, University Hospital Osijek, 31000 Osijek, Croatia
Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia
References (100+)
Show source-provided references
1. Urolithiasis through the ages10.1046/j.1464-410X.2002.02769.x ↗
2. Nephrolithiasis-Associated Renal Cell Carcinoma in Patients Who Underwent Nephrectomy: A Single-Center Experience10.14740/wjon1560 ↗
3. Trends in the prevalence of kidney stones in the United States from 2007 to 201610.1007/s00240-020-01210-w ↗
4. Skolarikos, A., Neisius, J.H., Somani, B., Tailly, T., Gambaro, G., Davis, N.F., Geraghty, R., Lombardo, R., and Tzelves, L. (2023, April 20). EAU Gidelines on Urolithiasis. Available online: https://uroweb.org/gidelines/urolithiasis.
5. Stamatelou, K., and Goldfarb, D.S. (2023). Epidemiology of Kidney Stones. Healthcare, 11.10.3390/healthcare11030424 ↗
6. History of kidney stones and the risk of coronary heart disease10.1001/jama.2013.8780 ↗
7. Kidney Stones Associate with Increased Risk for Myocardial Infarction10.1681/ASN.2010030253 ↗
8. Kidney Stones and the Risk for Chronic Kidney Disease10.2215/CJN.05811108 ↗
9. Nephrolithiasis and Risk of Incident Bone Fracture10.1016/j.juro.2015.12.069 ↗
10. International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis10.1007/s00240-022-01387-2 ↗
11. Physiopathology and etiology of stone formation in the kidney and the urinary tract10.1007/s00467-009-1116-y ↗
12. In Vitro Cell Culture Models of Hyperoxaluric States: Calcium Oxalate and Renal Epithelial Cell Interactions10.3390/cryst11070735 ↗
13. Nephrolithiasis: Molecular mechanism of renal stone formation and the critical role played by modulators10.1155/2013/292953 ↗
14. Nephrolithiasis10.1016/j.pop.2019.02.001 ↗
15. Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 202210.1016/j.euf.2022.06.014 ↗
16. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 203010.1016/j.eururo.2014.06.036 ↗
17. Kizivat, T., Smolić, M., Marić, I., Tolušić Levak, M., Smolić, R., Bilić Čurčić, I., Kuna, L., Mihaljević, I., Včev, A., and Tucak-Zorić, S. (2017). Antioxidant Pre-Treatment Reduces the Toxic Effects of Oxalate on Renal Epithelial Cells in a Cell Culture Model of Urolithiasis. Int. J. Environ. Res. Public Health, 14.10.3390/ijerph14010109 ↗
18. Antiurolithiatic plants: Multidimensional pharmacology
19. Protective effect of dietary polyphenol caffeic acid on ethylene glycol-induced kidney stones in rats10.1007/s00240-017-0982-1 ↗
20. Zhai, W., Zheng, J., Yao, X., Peng, B., Liu, M., Huang, J., Wang, G., and Xu, Y. (2013). Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat. BMC Complement. Altern. Med., 13.10.1186/1472-6882-13-228 ↗
21. Inhibitory effect of rutin and curcumin on experimentally-induced calcium oxalate urolithiasis in rats10.4103/0974-8490.75462 ↗
22. Diosmin Reduces Calcium Oxalate Deposition and Tissue Degeneration in Nephrolithiasis in Rats: A Stereological Study10.4111/kju.2013.54.4.252 ↗
23. Antiurolithiatic activity of natural constituents isolated from Aerva lanata10.1016/j.jaim.2016.11.006 ↗
24. Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo10.1016/S1734-1140(13)71078-8 ↗
25. Shakoor, H., Feehan, J., Apostolopoulos, V., Platat, C., Al Dhaheri, A.S., Ali, H.I., Ismail, L.C., Bosevski, M., and Stojanovska, L. (2021). Immunomodulatory Effects of Dietary Polyphenols. Nutrients, 13.10.3390/nu13030728 ↗
26. The effects of polyphenols and other bioactives on human health10.1039/C8FO01997E ↗
27. Di Lorenzo, C., Colombo, F., Biella, S., Stockley, C., and Restani, P. (2021). Polyphenols and Human Health: The Role of Bioavailability. Nutrients, 13.10.3390/nu13010273 ↗
28. Yahfoufi, N., Alsadi, N., Jambi, M., and Matar, C. (2018). The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients, 10.10.3390/nu10111618 ↗
29. Bioactivity of dietary polyphenols: The role of metabolites10.1080/10408398.2018.1546669 ↗
30. Stability of dietary polyphenols: It’s never too late to mend?10.1016/j.fct.2018.03.051 ↗
31. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity10.1016/j.foodchem.2022.132531 ↗
32. Plant phenolics as functional food ingredients10.1016/bs.afnr.2019.02.012 ↗
33. The double-edged roles of ROS in cancer prevention and therapy10.7150/thno.56747 ↗
34. Diversity of Chemical Structures and Biosynthesis of Polyphenols in Nut-Bearing Species10.3389/fpls.2021.642581 ↗
35. Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action10.3389/fphar.2022.806470 ↗
36. Kidney Stone Prevention10.1016/j.advnut.2023.03.002 ↗
37. Kidney stone proteomics: An update and perspectives10.1080/14789450.2021.1962301 ↗
38. Den Hartogh, D.J., and Tsiani, E. (2019). Health Benefits of Resveratrol in Kidney Disease: Evidence from In Vitro and In Vivo Studies. Nutrients, 11.10.3390/nu11071624 ↗
39. Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function10.1016/j.phymed.2018.12.024 ↗
40. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis10.1155/2019/5080843 ↗
41. Lipid Peroxidation Drives Renal Cyst Growth10.1681/ASN.2018010039 ↗
42. The mechanistic insight of polyphenols in calcium oxalate urolithiasis mitigation10.1016/j.biopha.2018.07.080 ↗
43. Gasmi, A., Mujawdiya, P.K., Noor, S., Lysiuk, R., Darmohray, R., Piscopo, S., Lenchyk, L., Antonyak, H., Dehtiarova, K., and Shanaida, M. (2022). Polyphenols in Metabolic Diseases. Molecules, 27.10.3390/molecules27196280 ↗
44. Fan, X., Fan, Z., Yang, Z., Huang, T., Tong, Y., Yang, D., Mao, X., and Yang, M. (2022). Flavonoids-Natural Gifts to Promote Health and Longevity. Int. J. Mol. Sci., 23.10.3390/ijms23042176 ↗
45. Ferroptosis: Past, present and future10.1038/s41419-020-2298-2 ↗
46. The Role of Ferroptosis in Acute Kidney Injury10.3389/fmolb.2022.951275 ↗
47. Ferroptosis: Molecular mechanisms and health implications10.1038/s41422-020-00441-1 ↗
48. Immunopathophysiology of trauma-related acute kidney injury10.1038/s41581-020-00344-9 ↗
49. Lesjak, M., Simin, N., and Srai, S.K.S. (2022). Can Polyphenols Inhibit Ferroptosis?. Antioxidants, 11.10.3390/antiox11010150 ↗
50. Hu, W., Liang, K., Zhu, H., Zhao, C., Hu, H., and Yin, S. (2022). Ferroptosis and Its Role in Chronic Diseases. Cells, 11.10.3390/cells11132040 ↗
51. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis10.1080/21655979.2021.1995994 ↗
52. Lin, C.H., Tseng, H.F., Hsieh, P.C., Chiu, V., Lin, T.Y., Lan, C.C., Tzeng, I.S., Chao, H.N., Hsu, C.C., and Kuo, C.Y. (2021). Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis. Biomedicines, 9.10.3390/biomedicines9091283 ↗
53. GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment10.1016/j.bbcan.2023.188890 ↗
54. Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis10.3892/ijmm.2020.4770 ↗
55. Regulated cell death pathways in kidney disease10.1038/s41581-023-00694-0 ↗
56. Ferroptosis, a Rising Force against Renal Fibrosis10.1155/2022/7686956 ↗
57. Su, Y., Liu, Z., Xie, K., Ren, Y., Li, C., and Chen, W. (2022). Ferroptosis: A Novel Type of Cell Death in Male Reproduction. Genes, 14.10.3390/genes14010043 ↗
58. Stepanić, V., and Kučerová-Chlupáčová, M. (2023). Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products. Molecules, 28.10.3390/molecules28020475 ↗
59. The role of quercetin in plants10.1016/j.plaphy.2021.05.023 ↗
60. Comparative metabolomics of flavonoids in twenty vegetables reveal their nutritional diversity and potential health benefits10.1016/j.foodres.2022.112384 ↗
61. Quercetin and its ester derivatives inhibit oxidation of food, LDL and DNA10.1016/j.foodchem.2021.130394 ↗
62. Quercetin alleviates acute kidney injury by inhibiting ferroptosis10.1016/j.jare.2020.07.007 ↗
63. Regulated Cell Death in AKI10.1681/ASN.2014030262 ↗
64. Chlorogenic acid, rutin, and quercetin from Lysimachia christinae alleviate triptolide-induced multi-organ injury in vivo by modulating immunity and AKT/mTOR signal pathway to inhibit ferroptosis and apoptosis10.1016/j.taap.2023.116479 ↗
65. Targeting of regulated necrosis in kidney disease10.1016/j.nefro.2017.04.004 ↗
66. The impact of oolong and black tea polyphenols on human health10.1016/j.fbio.2019.03.009 ↗
67. Green Tea, Black Tea, and Oolong Tea Polyphenols Reduce Visceral Fat and Inflammation in Mice Fed High-Fat, High-Sucrose Obesogenic Diets10.3945/jn.114.191007 ↗
68. The modulatory effect of polyphenols from green tea, oolong tea and black tea on human intestinal microbiota in vitro10.1007/s13197-017-2951-7 ↗
69. Effects of green tea on urinary stone formation: An in vivo and in vitro study10.1089/end.2006.20.356 ↗
70. Beneficial effects of green tea: A literature review10.1186/1749-8546-5-13 ↗
71. Antilithogenic potential of green tea, oolong tea, and black tea10.4103/pr.pr_67_19 ↗
72. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions10.1080/10408690390826464 ↗
73. Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases10.1093/advances/nmy077 ↗
74. Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction10.3389/fphar.2023.1142001 ↗
75. Association between tea intake and hospitalized nephrolithiasis in Chinese adults: A case-control study10.3389/fnut.2022.1014491 ↗
76. Macrophage M1/M2 polarization10.1016/j.ejphar.2020.173090 ↗
77. Effect of M2 Macrophages on Injury and Apoptosis of Renal Tubular Epithelial Cells Induced by Calcium Oxalate Crystals10.1159/000501558 ↗
78. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature10.3389/fimmu.2021.673690 ↗
79. (-)-Epigallocatechin-3-gallate (EGCG) modulates polarized macrophages to suppress M1 phenotype and promote M2 polarization in vitro and in vivo10.1016/j.jff.2021.104743 ↗
80. Kotha, R.R., and Luthria, D.L. (2019). Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects. Molecules, 24.10.3390/molecules24162930 ↗
81. A Critical Review of the Properties and Analytical Methods for the Determination of Curcumin in Biological and Pharmaceutical Matrices10.1080/10408347.2018.1489216 ↗
82. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives—A review10.1016/j.jtcme.2016.05.005 ↗
83. Molecular mechanisms of ferroptosis and relevance to inflammation10.1007/s00011-022-01672-1 ↗
84. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death10.1096/fj.201900077R ↗
85. Abbas, S. (2021). Green Synthesis, Characterization and In-Vitro Bioactivities of Gold Nanoparticles Mediated by Turmeric Crude Extract and Curcumin. [Ph.D. Thesis, Universiti Tun Hussein Onn Malaysia].
86. Puerarin prevents calcium oxalate crystal-induced renal epithelial cell autophagy by activating the SIRT1-mediated signaling pathway10.1007/s00240-022-01347-w ↗
87. Illana, G. (2017). Neuroprotection in Alzheimer’s Disease, Academic Press.
88. Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro10.1016/j.phymed.2021.153562 ↗
89. Alam, W., Khan, H., Shah, M.A., Cauli, O., and Saso, L. (2020). Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing. Molecules, 25.10.3390/molecules25184073 ↗
90. Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signalling10.1016/j.biopha.2018.10.195 ↗
91. In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids fromGingko biloba yellow leaves10.1007/BF02969294 ↗
92. Lin, C.W., Chen, P.N., Chen, M.K., Yang, W.E., Tang, C.H., Yang, S.F., and Hsieh, Y.S. (2013). Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. PLoS ONE, 8.10.1371/journal.pone.0080883 ↗
93. Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway10.1016/j.phymed.2021.153555 ↗
94. An In vitro Study of Orthosiphon stamineus (Misai Kucing) Standardized Water Extract as a Chemolytic Agent in Urolithiasis10.4103/jpbs.jpbs_526_21 ↗
95. Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2/HO-1 in the mouse model of stone formation10.1016/j.phymed.2022.154429 ↗
96. In Vitro Antilithiatic Potential of Kalanchoe pinnata, Emblica officinalis, Bambusa nutans, and Cynodon dactylon10.4103/JPBS.JPBS_18_18 ↗
97. Salehi, B., Mishra, A.P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P.V.T., Martins, N., and Sharifi-Rad, J. (2018). Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines, 6.10.3390/biomedicines6030091 ↗
98. Resveratrol Attenuates Oxalate-Induced Renal Oxidative Injury and Calcium Oxalate Crystal Deposition by Regulating TFEB-Induced Autophagy Pathway10.3389/fcell.2021.638759 ↗
99. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury10.1016/j.cbi.2021.109605 ↗
100. Antiurolithiatic Potential of Three Sri Lankan Medicinal Plants by the Inhibition of Nucleation, Growth, and Aggregation of Calcium Oxalate Crystals In Vitro10.1155/2022/8657249 ↗